In this issue:
ELOQUENT-3 - elotuzumab plus pomalidomide and dexamethasone for MM
Pomalidomide, cyclophosphamide, and dexamethasone at 1st relapse in MM after RVD therapy
A clinical prognostic score to identify early myeloma-related death in elderly patients
Guidelines on tools for the diagnosis and monitoring of MM
Nonsecretory and light chain escape in patients with MM
Next generation flow for quantification of tumor plasma cells in MGUS and MM at diagnosis
The progressive elevation of NT-proBNP during chemotherapy is related to asymptomatic cardiovascular events in patients with MM
GSK2857916 for RRMM
An early access treatment protocol of daratumumab in patients with RRMM
Evofosfamide for patients with RRMM
Please login below to download this issue (PDF)